Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its t:slim X2 pump. The company can now offer its automated insulin delivery (AID) system with Eli Lilly’s Lyumjev (insulin lispro-aabc injection) ultra-rapid-acting insulin in Europe. Previously, the t:slim X2 pump had clearance for use with Humalog and […]
Technology
Class action suit targets Abbott FreeStyle Libre amid claims of data sharing
Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre platform. ClassAction.org first reported on the claims. The lawsuit alleges that tracking tools on Abbott’s FreeStyle Libre website expose private consumer information without their knowledge or consent. Its FreeStyle.Abbott website provides educational tools for the continuous glucose […]
Senseonics wins FDA nod for 365-day implantable CGM
Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system. Eversense 365, an implantable continuous glucose monitor (CGM), becomes the world’s first 365-day CGM system, according to the company. Its indications cover people with type 1 and type 2 diabetes aged 18 years and older. The system also received clearance […]
Aptar Pharma inks dev deal with Pulmotree for non-propellant liquid inhaler platform
Aptar Pharma announced that it entered into an exclusive collaboration agreement with Pulmotree to develop a liquid inhaler platform. The collaboration enables Aptar to lead the development and promotion of the Kolibri non-propellant liquid inhaler (NPLI) platform. Under the agreement, Aptar intends to provide Pulmotree with full support to accelerate growth. The company serves as […]
Orange Biomed to showcase microfluidic-based A1C test
Orange Biomed announced today that it plans to showcase its microfluidic-based A1C test at the 2024 Diabetes Technology Meeting. The company intends to present research for the device during the event’s Startup Showcase next month. It developed the pocket-sized, single-cell, micro-electro-mechanical A1C analysis device, agnostic to hemoglobin variants, to deliver faster, more reliable results for […]
Dexcom CGM worn in outer space on Polaris Dawn mission
Dexcom (Nasdaq:DXCM) announced today that its G6 CGM is being worn by astronauts as part of the Polaris Dawn mission. Polaris Dawn launched this morning with astronauts wearing the G6 to better understand the effects of spaceflight on human health. The crew intends to conduct research to advance human health on Earth and the understanding […]
Abbott launches Lingo over-the-counter CGM biosensor in the U.S.
Abbott (NYSE:ABT) announced today that it made its Lingo continuous glucose monitoring system available without a prescription in the U.S. The technology is now available in the U.S. at hellolingo.com, as well as in the United Kingdom. Lingo features a biosensor and mobile app designed for customers who want to improve their overall health and […]
Beta Bionics to pair bionic pancreas with Abbott FreeStyle Libre 3 Plus
Beta Bionics announced that it partnered with Abbott (NYSE:ABT) to integrate the company’s CGM with its automated insulin delivery system. The companies plan to combine Abbott’s FreeStyle Libre 3 Plus continuous glucose monitor (CGM) with the Beta Bionics iLet bionic pancreas. According to Beta Bionics, this will make iLet the first available AID system to […]
Embecta wins FDA clearance for disposable insulin patch pump
Embecta (Nasdaq:EMBC) announced today that it received FDA 510(k) clearance for its proprietary disposable insulin delivery system. The open-loop system is indicated for adults who require insulin to manage diabetes, including both type 1 and type 2 diabetes. It features a tubeless design with a 300-unit insulin reservoir, informed by feedback from people with type […]
Glytec, Roche expand diabetes management collaboration
Glytec announced today that it expanded its collaboration with Roche to integrate software with smart diabetes technology. The two companies initially struck a partnership in early 2022. They aimed to combine Glytec’s FDA-cleared Glucommander insulin dosing decision support software with Roche’s expertise in medical devices and IT solutions. It marked an effort to address the […]